Related Experiment Video
Updated: May 22, 2026

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Malignancy in solitary solid cold thyroid nodule.
M Fariduddin1, A H Amin, M U Ahmed
1Head Endocrine Wing (White Unit) Department of Medicine, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh. dr.md.fariduddin@gmail.com
Mymensingh Medical Journal : MMJ
|May 8, 2012
Summary
This study on solitary thyroid nodules found malignancy in 32.3% of cases. Solid cold nodules had a higher, though not statistically significant, malignancy rate compared to mixed nodules.
Area of Science:
- Endocrinology
- Oncology
- Diagnostic Imaging
Background:
- Solitary thyroid nodules are common, with the primary concern being the exclusion of malignancy.
- Accurate differentiation between benign and malignant nodules is crucial to minimize unnecessary surgeries.
Purpose of the Study:
- To evaluate the diagnostic accuracy of ultrasound (USG) and fine-needle aspiration cytology (FNAC) in differentiating malignant from benign solitary thyroid nodules.
- To assess the malignancy rates in solid versus mixed consistency cold nodules.
Main Methods:
- A study of 127 patients with solitary thyroid nodules who were clinically and biochemically euthyroid and had cold nodules on radionuclide scan.
- Diagnostic procedures included hormone assessment, USG, FNAC, and surgical intervention.
- Postoperative histopathological examination was used as the gold standard for diagnosis.
Main Results:
- Histopathology confirmed malignancy in 41 (32.3%) of the 127 solitary thyroid nodules.
- Solid cold nodules showed a 34.6% malignancy rate, while mixed cold nodules had a 21.7% malignancy rate.
- FNAC results indicated 65.5% benign, 7.8% suspicious, and 26.7% malignant findings.
Conclusions:
- Histopathology remains the definitive method for diagnosing malignancy in solitary thyroid nodules.
- While solid cold nodules exhibited a higher malignancy rate, the difference was not statistically significant compared to mixed cold nodules.
- Further research may refine diagnostic strategies to improve preoperative differentiation and patient management.
Related Concept Videos
Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
